+B|0QU5;|EF8:XD(L#=#P}#))O7
SYSTEM PROCESSING...
+B|0QU5;|EF8:XD(L#=#P}#))O7
SYSTEM PROCESSING...
Posted: 2025-04-24 05:00:12 UTC
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
This article contains some claims that remain unverified. While much of the content may be accurate, exercise care when relying on this information.
Status
Last Updated
2025-04-24 05:01:44 UTC
Verified By
Rollup News
A study published in EHJPharmacotherapy investigates the impact of SGLT2 inhibitors on renal outcomes in patients with type 2 diabetes, considering BMI as a factor. The research reveals new evidence regarding the kidney-protective effects of SGLT2 inhibitors across various BMI ranges, with a more pronounced effect in individuals with higher BMI.
SGLT2 inhibitors' influence on renal outcomes
Impact of BMI on the effectiveness of SGLT2 inhibitors
Kidney-protective effects across different BMI ranges
Annual eGFR decline